Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 89

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 89
---
 The Company adopted this guidance on January 1, 2023. The adoption of this accounting standard did not have an impact on the Company’s consolidated financial statements as the Company is in a pre-revenue state and does not generate revenue and has no receivables from third party.

| 73 |

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires incremental disclosure of segment information on an interim and annual basis. This ASU is effective for public entities for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Retrospective application to all prior periods presented in the financial statements is required for public entities. The Company adopted ASU 2023-07 as of January 1, 2024, which resulted in additional disclosures of significant segment expenses and other segment items as well as incremental qualitative disclosures.

Other recent accounting pronouncements issued by the FASB (including its Emerging Issues Task Force), the AICPA and the SEC did not or are not believed by management to have a material impact on the Company’s present or future consolidated financial statements.

2. ACCOUNTS RECEIVABLE

Accounts receivable were comprised of the following:

SCHEDULE OF ACCOUNTS RECEIVABLE

|                         |     |   |          As of 
 March 31, 2025 |     |   |     As of 
 September 
  30, 2024 |
|:------------------------|:----|:--|---------------:|:----|:--|----------:|
| Licensee- Related Party |     |   |        149,723 |     |   |    94,873 |
| Total                   |     | $ |        149,723 |     | $ |    94,873 |

During the quarter ended March 31, 2025 there was no allowance for doubtful accounts.

3. PREPAID EXPENSES

Prepaid Expenses were comprised of the following:

SCHEDULE OF PREPAID EXPENSES

|                  |     |   |          As of 
 March 31, 2025 |     |   |             As of 
 September 30,2024 |
|:-----------------|:----|:--|---------------:|:----|:--|------------------:|
| Prepaid Expenses |     | $ |            265 |